SavedAdd your journal

Journals / Molecular Oncologic Imaging / 2026 / Volume: 5 Issue: 1

F-18 Fluorodeoxyglucose and Ga-68 Peptide Receptor Imaging of Cervix Mixed Large Cell Carcinoma Patient Presented With Brain Metastasis

Gülsüm Ayrık(MERSIN UNIVERSITY)0009-0005-3811-6425
Zehra Pınar Koç(MERSIN UNIVERSITY)0000-0002-3274-5790
Pınar Pelin Özcan(MERSIN UNIVERSITY)0000-0003-0147-2678
Ayşe Türkmen Dedeoğlu(MERSIN UNIVERSITY)0000-0003-3160-941X
Hamide Sayar(MERSIN UNIVERSITY)0000-0002-8273-2605
Vehbi Erçolak(MERSIN UNIVERSITY)0000-0003-1014-1694
Pages
—
Publication Date
2025-05-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report represents the 18F FDG and Ga-68 DOTATATE PET-CT images of the patient presented with brain metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cervix mixt adenoneuroendocrine carcinoma (MANEC) are rare and agressive types which present with metastasis early in the disease course.
📊
Key Findings & Data:Cervix mixt adenoneuroendocrine carcinoma (MANEC) are rare and agressive types which present with metastasis early in the disease course.
💡
Conclusion & Impact:This case report represents the 18F FDG and Ga-68 DOTATATE PET-CT images of the patient presented with brain metastasis.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:adenoneuroendocrine · FDG · dotatate

Abstract

Cervix mixt adenoneuroendocrine carcinoma (MANEC) are rare and agressive types which present with metastasis early in the disease course. This case report represents the 18F FDG and Ga-68 DOTATATE PET-CT images of the patient presented with brain metastasis.

🔖

Cite This Article

Ayrık, G., Koç, Z. P., Özcan, P. P., Dedeoğlu, A. T., Sayar, H., Erçolak, V. (2025). F-18 Fluorodeoxyglucose and Ga-68 Peptide Receptor Imaging of Cervix Mixed Large Cell Carcinoma Patient Presented With Brain Metastasis. Molecular Oncologic Imaging, Volume: 5 Issue: 1. https://doi.org/10.71286/moi.1696337

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Giovannini E, Giovacchini G, Borsò E, et al. [68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications. Curr. Radiopharm 2019;12:11-22.
  2. Tirosh, A., & Kebebew, E. (2018). The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future oncology (London, England), 14(2), 111–122. https://doi.org/10.2217/fon-2017-0393
  3. Gurzu, S., Kadar, Z., Bara, T., Bara, T., Jr, Tamasi, A., Azamfirei, L., & Jung, I. (2015). Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases. World journal of gastroenterology, 21(4), 1329–1333. https://doi.org/10.3748/wjg.v21.i4.1329
  4. Wei, K. N., Fu, X. D., Wang, M. Y., & Wang, L. X. (2024). Two cases of mixed large cell neuroendocrine carcinoma and adenocarcinoma of the cervix: case report and review of the literature. Diagnostic pathology, 19(1), 166. https://doi.org/10.1186/s13000-024-01592-0